Molecular mechanisms of chronic hepatitis C progression
Molecular mechanisms of chronic hepatitis C progression
批准号:
15590649
负责人:
IWASAKI Yoshiaki
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background and Aims : It has been reported that dendritic cells (DC) of chronic hepatitis C patients showed reduced allo-stimulatory function. However, the exact mechanisms of this phenomenon are not well defined. To investigate the component of HCV polyprotein that has the most important effect on DC cell function, we examined the modulatory effects of 7 HCV protein genes (g-core, g-NS2, g-NS3, g-NS4A, g-NS4B, g-NS5A, and g-NS5B) and 5 recombinant proteins (p-core, p-NS3, p-NS4, p-NS5A, and p-NS5B) on the DC surface marker expression and its functions.Methods : Peripheral blood mononuclear cells (PBMC) were separated from healthy volunteers using a Ficoll gradient, and CD14+ cells were enriched using CD14 microbeads. On day 5, the cells were harvested and pulsed with 7 HCV protein plasmids by the lipofection method or incubated with 5 recombinant HCV proteins. After culturing for 48 hrs, the cells were assayed for cell surface marker expression by flow cytometric analysis. For cytokin … More e analysis and proliferative T cell response analysis, the immature DC and LPS matured DC were cultured with auto CD4+ T cells and PPD 0.1 microgram / well. After 2 more days of culture, the supernatants were measured for cytokine concentration. After a further 3 days of culture, 3H-thymidine uptake was measured. The results were all shown as the ratio of HCV protein data to data of the control vector or buffer control.Results : The NS4A and NS4B genes and NS4 protein reduced the expression of CD86. The NS4B and NS5A genes and NS4 protein induced relatively low T cell responses. Cytokines of the culture supernatant showed that the concentration of Th1 cytokines of the supernatants were low in g-NS4 transduced and p-NS4 - added DC and CD4 T cell cocultures. However, these effects of HCV proteins on DC function were all restored by LPS maturation.Conclusion : HCV NS4 protein may reduce the CD86 expression levels and the function of DC and hamper the Th1 immune responses. However, this effect can be restored when the DCs were well matured. Less
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/j.1478-3231.2004.0956.x
发表时间:
2004-12-01
期刊:
LIVER INTERNATIONAL
影响因子:
6.7
作者:
[Iwasaki, Y, Takaguchi, K, Shiratori, Y]
通讯作者:
Shiratori, Y
Intrahepatic mRNA levels of type I interferon receptor and interferon-stimulated genes in genotype 1b chronic hepatitis C-The association between IFNAR1 mRNA level and sustained response to interferon therapy.
基因型 1b 慢性丙型肝炎中 I 型干扰素受体和干扰素刺激基因的肝内 mRNA 水平-IFNAR1 mRNA 水平与干扰素治疗持续反应之间的关联。
DOI:
--
发表时间:
2006
期刊:
Intervirology (in press)
影响因子:
--
作者:
[Tahiguchi H, Iwasaki Y, Shiratori Y, et al.]
通讯作者:
et al.
DOI:
10.1002/hep.20984
发表时间:
2006-01-01
期刊:
HEPATOLOGY
影响因子:
13.5
作者:
[Iwasaki, Y, Ikeda, H, Shiratori, Y]
通讯作者:
Shiratori, Y
C型肝炎ウイルス(HCV)構成遺伝子導入及びHCVタンパク貪食による樹状細胞機能の変化
丙型肝炎病毒(HCV)组成基因导入和HCV蛋白吞噬作用导致树突状细胞功能发生变化
DOI:
--
发表时间:
2005
期刊:
肝臓 46Suppl.2
影响因子:
--
作者:
[高木章乃夫, 岩崎良章, 白鳥康史]
通讯作者:
白鳥康史
Risk factors for hepatocellular carcinoma in Hepatities C patients with sustained virologic response to interferon therapy.
对干扰素治疗有持续病毒学反应的丙型肝炎患者发生肝细胞癌的危险因素。
DOI:
--
发表时间:
2004
期刊:
Liver Int. 24
影响因子:
--
作者:
[Iwasaki Y, Shiratori Y, et al.]
通讯作者:
et al.
共 13 条
Establishment and application of animal model of liver cancer stem cell using induced pluripotent stem cells
-
批准号:16K07116
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2016
-
负责人:IWASAKI Yoshiaki
-
依托单位:
Analysis of genetic predisposition in relation to prognosis and response to therapy in liver diseases
-
批准号:22590733
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:IWASAKI Yoshiaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
LILRB2/HLA-G免疫抑制轴在胶质瘤干细胞免疫逃逸中的作用及其与STAT3信号通路的交互调控机制研究
-
批准号:2026JJ80459
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王彪
-
依托单位:
HLA-DR+中性粒细胞调控儿童噬血细胞综合征细胞因子风暴的机制及临床价值研究
-
批准号:2026JJ81611
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘灿
-
依托单位:
HLA-B*13:01介导阿苯达唑肝损伤的毒理机制及构效关系研究
-
批准号:2026JJ50638
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:饶泰
-
依托单位:
肝内胆管细胞癌中TREM2+巨噬细胞通过增强HLA-C/FAM3C信号通路依赖性淋巴管生成促进肿瘤转移的机制研究
-
批准号:QN25H160111
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:万喆
-
依托单位:
HLA-B27通过肠道菌群失衡致炎促AS发展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郑海雅
-
依托单位:
三阴性乳腺癌HLA-I和HLA-II限制性T细胞表位鉴定与免疫治疗
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邵营宽
-
依托单位:
EBV高危亚型编码的BALF2-HR蛋白上调HLA-II类分子促进鼻咽癌免疫逃逸的机制研究
-
批准号:2025JJ60152
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:葛军尚
-
依托单位:
HLA-C 提高CAR-T 细胞治疗急性淋巴细胞白血病效能及机制的探讨
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张诚
-
依托单位:
HLA-G在胃癌发生发展中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:章霞
-
依托单位:
KIR-HLA受配体相合度对免疫性血小板输注无效的影响及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位: